Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Scheen

Showing results (201-210 of 787) with videos related to

Pageof 79
Sort By:
Revue Medicale De Liege|August 1, 2009
[International classification of various types of monoclonal antibodies]A J Scheen
Revue Medicale De Liege|August 1, 2009
[New advances in therapeutic use of monoclonal antibodies]A J Scheen
Revue Medicale De Liege|March 17, 2012
[The "Revue Medicale de Liege", publishing trends in changing society and medicine ]A J Scheen
Revue Medicale De Liege|April 1, 1996
[How I treat... A Type 2 diabetic patient who has become insulin-dependent]A J Scheen
Revue Medicale De Liege|January 1, 1996
[Hypoglycemic sulfamides, 50 years after Loubatiere]A J Scheen
Revue Medicale De Liege|November 1, 1995
[Pharma clinics. Drug of the month. Acipimox (Olbetam)]A J Scheen
Revue Medicale De Liege|November 1, 1995
[Secondary effects of fluoroquinolones: experience of French drug monitoring]A J Scheen
Revue Medicale Suisse|September 13, 2013
[Integrating evidence-based medicine and personalized medicine]A J Scheen
Revue Medicale De Liege|August 20, 2015
[PHARMACEUTICAL INDUSTRY AND PERSONALIZED MEDICINE: A PARADIGM SHIFT IN THE DEVELOPMENT OF NEW DRUGS]A J Scheen
Diabetes & Metabolism|February 3, 2020
Reduction in HbA1c with SGLT2 inhibitors vs. DPP-4 inhibitors as add-ons to metformin monotherapy according to baseline HbA1c: A systematic review of randomized controlled trialsA J Scheen
Pageof 79

Showing results (201-210 of 787) with videos related to

Sort By:
Pageof 79
Revue Medicale De Liege|August 1, 2009
[International classification of various types of monoclonal antibodies]A J Scheen
Revue Medicale De Liege|August 1, 2009
[New advances in therapeutic use of monoclonal antibodies]A J Scheen
Revue Medicale De Liege|March 17, 2012
[The "Revue Medicale de Liege", publishing trends in changing society and medicine ]A J Scheen
Revue Medicale De Liege|April 1, 1996
[How I treat... A Type 2 diabetic patient who has become insulin-dependent]A J Scheen
Revue Medicale De Liege|January 1, 1996
[Hypoglycemic sulfamides, 50 years after Loubatiere]A J Scheen
Revue Medicale De Liege|November 1, 1995
[Pharma clinics. Drug of the month. Acipimox (Olbetam)]A J Scheen
Revue Medicale De Liege|November 1, 1995
[Secondary effects of fluoroquinolones: experience of French drug monitoring]A J Scheen
Revue Medicale Suisse|September 13, 2013
[Integrating evidence-based medicine and personalized medicine]A J Scheen
Revue Medicale De Liege|August 20, 2015
[PHARMACEUTICAL INDUSTRY AND PERSONALIZED MEDICINE: A PARADIGM SHIFT IN THE DEVELOPMENT OF NEW DRUGS]A J Scheen
Diabetes & Metabolism|February 3, 2020
Reduction in HbA1c with SGLT2 inhibitors vs. DPP-4 inhibitors as add-ons to metformin monotherapy according to baseline HbA1c: A systematic review of randomized controlled trialsA J Scheen
Pageof 79